The Use of Standardized Incidence and Prevalence Rates in Epidemiological Studies on Multiple Sclerosis
The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Objective: To demonstrate whether or not the age and sex adjustment of incidence and prevalence rates in multiple sclerosis (MS) could allow more reliable comparison between epidemiological studies performed in different areas of the world and to establish if the latitude gradient theory could be confirmed after the standardization for age and sex distribution. Methods: A meta-analysis of population-based incidence and prevalence studies on MS from 1980 through 1998 using the terms ‘multiple sclerosis’, ‘prevalence’ and ‘incidence’ in the bibliographic databases MEDLINE and EMBASE was performed. We included studies that reported the diagnostic criteria, number of cases and the population studied, the date of the study, the latitude, and the age- and sex-specific crude incidence and prevalence rates. According to the inclusion criteria, 69 of 127 papers on prevalence and 22 of 70 papers on incidence were considered for age adjustment and 27 prevalence and 8 incidence studies for sex adjustment. The mean incidence and prevalencerates and the 95% confidence intervals age- and sex-adjusted to the World and the European standard populations were calculated. Results: The Spearman rank correlation and the multiple regression analyses indicated that age adjustment to standard populations could overcome the limitations in comparing the crude prevalence and incidence rates of different epidemiological studies on MS. When the mean crude and age- and sex-adjusted prevalence and age-adjusted incidence rates were stratified by latitude (from south to north), the latitudinal gradient, which was highly significant for the crude rates, became less remarkable for the age- and sex-adjusted prevalence rates and not significant for the age-adjusted incidence rates. Conclusions: The crude incidence and prevalence rates in epidemiological studies on MS should be age- and sex-adjusted to a common standard population to permit a more reliable comparison among studies performed in different countries. Our findings support the opinion that the latitude does not play a key role in determining the onset of MS. Whenever possible, the crude incidence and prevalence rates should be adjusted to the ethnic origin and migration characteristics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“but lower than that reported for multiple sclerosis (65–74 per 100 000 people),47 dementias (4·2–8·0% in people aged 60 years or older),48 and stroke (0·4–2·1% in low-income and middle-income countries).49”
From Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2017) · cites this paper as [47]
Citations
Cites
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Schumacher, G. A., Beebe, G., Kibler, R. F., Kurland, L. T., Kurtzke, J. F., McDowell, F., Nagler, B., Sibley, W. A., Tourtellotte, W. W., & Willmon, T. L. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb20235.x · Cited by 1,438
Multiple Sclerosis: A Reappraisal
(1973) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb110785.x · Cited by 545
The epidemiology of multiple sclerosis
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802973-2.00011-2 · Cited by 514
DIAGNOSIS AND CLASSIFICATION OF MULTIPLE SCLEROSIS
MCDONALD, W. I., & HALLIDAY, A. M. (1977) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071393 · Cited by 446
Criteria for the clinical diagnosis of multiple sclerosis
ROSE, A. S., ELLISON, G. W., MYERS, L. W., & TOURTELLOTTE, W. W. (1976) · Neurology · doi:10.1212/wnl.26.6_part_2.20 · Cited by 371
How to report statistics in medicine: annotated guidelines for authors, editors, and reviewers
(1997) · Choice Reviews Online · doi:10.5860/choice.35-1556 · Cited by 308
Epidemiology of Multiple Sclerosis: A Critical Overview
Sadovnick, A. D., & Ebers, G. C. (1993) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100047351 · Cited by 304
On the Risk of Multiple Sclerosis According to Age at Immigration to South Africa
Dean, G., & Kurtzke, J. F. (1971) · BMJ · doi:10.1136/bmj.3.5777.725 · Cited by 303
The Epidemiology of Multiple Sclerosis
Hogancamp, W. E., Rodriguez, M., & Weinshenker, B. G. (1997) · Mayo Clinic Proceedings · doi:10.4065/72.9.871 · Cited by 225
Cited by
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Feigin, V. L., Abajobir, A. A., Abate, K. H., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Abyu, G. Y., Ahmed, M. B., Aichour, A. N., Aichour, I., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30299-5 · Cited by 2,275
How common are the "common" neurologic disorders?
Hirtz, D., Thurman, D. J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A. R., & Zalutsky, R. (2007) · Neurology · doi:10.1212/01.wnl.0000252807.38124.a3 · Cited by 1,365
The changing demographic pattern of multiple sclerosis epidemiology
Koch-Henriksen, N., & Sørensen, P. S. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70064-8 · Cited by 1,191
HOW COMMON ARE THE “COMMON” NEUROLOGIC DISORDERS?
Kaplin, A. I., & Williams, M. (2007) · Neurology · doi:10.1212/01.wnl.0000278071.91524.4d · Cited by 1,131
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
Simpson, S., Blizzard, L., Otahal, P., Van der Mei, I., & Taylor, B. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2011.240432 · Cited by 718
“Asia and Pacific 16 (16) 32 (32) 6 (6) 4 (4)”
Temporal trends in the incidence of multiple sclerosis: A systematic review
Alonso, A., & Hernán, M. A. (2008) · Neurology · doi:10.1212/01.wnl.0000316802.35974.34 · Cited by 694
The epidemiology of multiple sclerosis in Europe
Pugliatti, M., Rosati, G., Carton, H., Riise, T., Drulovic, J., Vécsei, L., & Milanov, I. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01342.x · Cited by 654
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
Kingwell, E., Marriott, J. J., Jetté, N., Pringsheim, T., Makhani, N., Morrow, S. A., Fisk, J. D., Evans, C., Béland, S. G., Kulaga, S., et al. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-128 · Cited by 520
Epidemiology of multiple sclerosis
Leray, E., Moreau, T., Fromont, A., & Edan, G. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2015.10.006 · Cited by 478
“[55] Zivadinov R, Iona L, Monti-Bragadin L, Bosco A, Jurjevic A, Taus C, et al.”
Environmental risk factors in multiple sclerosis aetiology
Marrie, R. A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00933-0 · Cited by 359
Prevalence of immune thrombocytopenia: analyses of administrative data
SEGAL, J. B., & POWE, N. R. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02147.x · Cited by 270
Burneo, J. G., Tellez-Zenteno, J., & Wiebe, S. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.07.002 · Cited by 226
Incidence and Prevalence of Multiple Sclerosis in the Americas: A Systematic Review
Evans, C., Beland, S.-G., Kulaga, S., Wolfson, C., Kingwell, E., Marriott, J., Koch, M., Makhani, N., Morrow, S., Fisk, J., et al. (2013) · Neuroepidemiology · doi:10.1159/000342779 · Cited by 211
Simpson, S., Wang, W., Otáhal, P., Blizzard, L., van der Mei, I. A. F., & Taylor, B. V. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-320189 · Cited by 205
Role of return migration in the emergence of multiple sclerosis in the French West Indies
Cabre, P., Signaté, A., Olindo, S., Merle, H., Caparros-Lefebvre, D., Béra, O., & Smadja, D. (2005) · Brain · doi:10.1093/brain/awh624 · Cited by 160
“Denominators used to calculate the incidence and prevalence of multiple sclerosis as a function of migration status for the 15–64 age range were extrapolated from the results of the poll, and direct age standardization was used to account for different population structures (Zivadinov et al., 2003).”
MethodNational and Regional Prevalence of Self‐reported Epilepsy in Canada
Téllez‐Zenteno, J. F., Pondal‐Sordo, M., Matijevic, S., & Wiebe, S. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.24904.x · Cited by 142
“These intriguing apparent differences persisted after adjusting for age, which can be an important confounder when assessing geographic variations in prevalence (23).”
BackgroundEpidemiology of multiple sclerosis in Europe: A Review
Koutsouraki, E., Costa, V., & Balogiannis, S. (2010) · International Review of Psychiatry · doi:10.3109/09540261003589216 · Cited by 144
“The latitude does not play a key role in determining the onset of MS (Zivadinov et al., 2003).”
BackgroundInfluentialTemporal trends in multiple sclerosis prevalence and incidence in a large population
Rotstein, D. L., Chen, H., Wilton, A. S., Kwong, J. C., Marrie, R. A., Gozdyra, P., Krysko, K. M., Kopp, A., Copes, R., & Tu, K. (2018) · Neurology · doi:10.1212/wnl.0000000000005331 · Cited by 105
“Although regional differences may exist, some of the conflicting findings in the literature likely stem from common limitations of MS epidemiologic studies, including a lack of one or more of the following: population-based samples, standardization for age and sex, and information regarding mortality rates.(2,3,10,11)…”
BackgroundMS prevalence in New Zealand, an ethnically and latitudinally diverse country
Taylor, B. V., Pearson, J. F., Clarke, G., Mason, D. F., Abernethy, D. A., Willoughby, E., & Sabel, C. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510379614 · Cited by 102
Latitudinal variation in incidence and type of first central nervous system demyelinating events
Taylor, B. V., Lucas, R. M., Dear, K. B. G., Kilpatrick, T. J., Pender, M. P., van der Mei, I. A. F., Chapman, C., Coulthard, A., Dwyer, T., McMichael, A. J., et al. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458509359724 · Cited by 103
“It is also important to note that, in this study, latitudinal incidence rate gradients persisted and were only marginally altered after age and sex standardization, in contrast to the findings of Zivadinov et al.(30) We found that the absolute incidence of each FDE phenotype varied by latitude.”
ResultGatenby, P. A., Lucas, R. M., Engelsen, O., Ponsonby, A., & Clements, M. (2009) · Arthritis Care & Research · doi:10.1002/art.24790 · Cited by 90
“The single comparable meta-analytic study of multiple sclerosis (46) found a nonsignificant latitudinal increase in age-adjusted incidence.”
BackgroundIncreasing incidence of multiple sclerosis among women in Lorraine, Eastern France
Debouverie, M., Pittion-Vouyovitch, S., Louis, S., Roederer, T., & Guillemin, F. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507077938 · Cited by 89
“Nevertheless, latitude does not play a key role in determining the onset of MS [4].”
BackgroundIncidence of multiple sclerosis in the United Kingdom: Findings from a population-based cohort
Alonso, Á., Jick, S. S., Olek, M. J., & Hernán, M. Á. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0602-z · Cited by 103
McGuigan, C. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.012666 · Cited by 82
Is it time for a new global classification of multiple sclerosis?
Melcon, M. O., Correale, J. D., & Melcon, C. M. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.06.051 · Cited by 99
“These findings indicate that latitude does not play a key role in MS frequency while both genetic susceptibility and environmental factors play a more important role than geography in MS prevalence [91].”
BackgroundTherapy Insight: bladder dysfunction associated with multiple sclerosis
Kalsi, V., & Fowler, C. J. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0323 · Cited by 77
Koch‐Henriksen, N., & Sørensen, P. S. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.09.003 · Cited by 99
Foulon, S., Maura, G., Dalichampt, M., Alla, F., Debouverie, M., Moreau, T., & Weill, A. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8513-0 · Cited by 93
“The methodological quality of epidemiological studies, therefore, is highly variable but has improved in the more recent studies due to the use of administrative databases [2, 14].”
BackgroundThe prevalence of multiple sclerosis in 3 US communities.
(2010) · PubMed Central · Cited by 75
Increasing prevalence and incidence of multiple sclerosis in northern Japan
Houzen, H., Niino, M., Hata, D., Nakano, F., Kikuchi, S., Fukazawa, T., & Sasaki, H. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508090226 · Cited by 73
“A systematic meta-analysis reported that this apparent relationship diminishes when estimates are ageand sex-adjusted to a common standard population [2].”
BackgroundIndividual and Joint Action of Environmental Factors and Risk of MS
van der Mei, I. A. F., Simpson, S., Stankovich, J. M., & Taylor, B. V. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2010.12.007 · Cited by 77
Estimation of the cost of MS in Europe: Extrapolations from a multinational cost study
Sobocki, P., Pugliatti, M., Lauer, K., & Kobelt, G. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507077941 · Cited by 77
“Defining the distribution of MS in space and time is therefore undermined by several methodological concerns, such as 1) the variability of the surveyed populations with respect to size, age structure, ethnic origin [40]; 2) the different sensitivity of case ascertainment with regards to benign and very early cases [4…”
MethodSarasoja, T., Wikstrom, J., Paltamaa, J., Hakama, M., & Sumelahti, M.-L. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00326.x · Cited by 64
Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan
Hader, W. J., & Yee, I. M. L. (2007) · Neurology · doi:10.1212/01.wnl.0000276991.13764.77 · Cited by 64
Peiris, M., Monteith, G. R., Roberts‐Thomson, S. J., & Cabot, P. J. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.03.013 · Cited by 68
Causes of Uveitis in a Tertiary Center in Chile: A Cross-sectional Retrospective Review
Liberman, P., Gauro, F., Berger, O., & Urzúa, C. A. (2014) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2014.981548 · Cited by 66
“10 per 100,000 people,(20) less than half the worldwide incidence.(21) TABLE 7.”
BackgroundLatitudinal prevalence gradient of multiple sclerosis in Latin America
Risco, J., Maldonado, H., Luna, L. V., Osada, J., Ruiz, P., Juarez, A., & Vizcarra, D. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511405562 · Cited by 73
“Finally, we used crude prevalence rates to study latitudinal variation, where age-adjusted prevalence would have been more appropriate in comparisons between different studies.(30) The information presented is incomplete, with most countries in the region not represented.”
MethodMultiple Sclerosis in Latin America
Corona, T., & Román, G. C. (2005) · Neuroepidemiology · doi:10.1159/000089230 · Cited by 62
Reproduction and the risk of multiple sclerosis
Magyari, M., Koch‐Henriksen, N., Pfleger, C., & Sørensen, P. S. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513481397 · Cited by 68
Argentine Patagonia: prevalence and clinical features of multiple sclerosis
Melcon, M. O., Ls, G., Carrá, A., Cáceres, F., Correale, J. D., Cristiano, E., Liguori, N. F., Garcea, O., Luetic, G. G., & Kremenchutzky, M. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507085801 · Cited by 59
“Epidemiological studies of MS conducted during the last decade showed that genetic susceptibility plays a more important role than geography and latitude in determining MS prevalence [8,15,22].”
BackgroundMethodTrends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009
Simpson, S., Pittas, F., van der Mei, I. A. F., Blizzard, L., Ponsonby, A., & Taylor, B. V. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.215186 · Cited by 56
Multiple Sclerosis Epidemiology in Europe
Bezzini, D., & Battaglia, M. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-47861-6_9 · Cited by 98
Prevalence of Multiple Sclerosis in Canada: A Systematic Review
Poppe, A. Y., Wolfson, C. M., & Zhu, B. (2008) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100009380 · Cited by 71
“37,44 Canada serves as an ideal territory for the study of MS epidemiology given the high prevalence of disease, regional variation, the presence of a well-established community of MS researchers and publicly-funded, universally accessible healthcare.”
Kizelsztein, P., Komarnytsky, S., & Raskin, I. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.08.017 · Cited by 48
“Approximately 2 million people worldwide, and about 350,000 people in the United States alone have multiple sclerosis (MS), the most common debilitating illness among young adults (Zivadinov et al., 2003).”
BackgroundThe Prevalence of Multiple Sclerosis in the Middle East
Al-Hashel, J. Y., Besterman, A. D., & Wolfson, C. M. (2008) · Neuroepidemiology · doi:10.1159/000151514 · Cited by 48
Prevalence and Incidence of Multiple Sclerosis in Las Palmas, Canary Islands, Spain
Aladro, Y., Alemany, M., Pérez‐Vieitez, M. C., Amela, R., Conde, M., Reyes, M., Santana, F. Á., & Ángel-Moreno, A. (2004) · Neuroepidemiology · doi:10.1159/000081052 · Cited by 42
Phillips, C. J. (2004) · CNS Drugs · doi:10.2165/00023210-200418090-00002 · Cited by 51
Mastorodemos, V. C., Ιωάννου, Μ., & Verginis, P. (2014) · NeuroImmunoModulation · doi:10.1159/000362370 · Cited by 46
Kuerten, S., & Angelov, D. N. (2008) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2007.11.001 · Cited by 40
Towards establishing MS prevalence in Latin America and the Caribbean
Melcon, M. O., Melcon, C. M., Bartoloni, L. C., Cristiano, E., Durán, J. C., Grzesiuk, A. K., Fragoso, Y. D., Brooks, J. B. B., Díaz, V., García, K. R., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512441985 · Cited by 46
The role of epidemiology in MS research: Past successes, current challenges and future potential
Simpson, S., Taylor, B. V., & van der Mei, I. A. F. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515574896 · Cited by 45
Multiple sclerosis: an update for oral health care providers
Fischer, D. J., Epstein, J. B., & Klasser, G. D. (2009) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2009.05.047 · Cited by 35
The Role of the Neurologist in the Longitudinal Management of Normal Pressure Hydrocephalus
Wilson, R. K., & Williams, M. A. (2010) · The Neurologist · doi:10.1097/nrl.0b013e3181de4907 · Cited by 27
“Most general neurologists diagnose at least a few new patients each year with multiple sclerosis, and the prevalence of NPH in patients older than 65 is similar to the general prevalence of multiple sclerosis.(6,7) Thus, NPH is common enough that a neurologist may diagnose several cases each year that must be treated…”
BackgroundMagalhaes, S., Pugliatti, M., Riise, T., Myhr, K., Ciampi, A., Bjørnevik, K., & Wolfson, C. M. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy269 · Cited by 28
Cristiano, E., Patrucco, L., Míguez, J., Giunta, D. H., Peroni, J., & Rojas, J. I. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2637-3 · Cited by 22
“Rates were adjusted using direct standardization with the age and gender distribution of the 2010 Buenos Aires population and the 2010 Argentinean population [1, 2, 24, 25].”
MethodCristiano, E., Patrucco, L., Giunta, D. H., Videla, G., Soriano, E. R., & Rojas, J. I. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02846.x · Cited by 22
“Rates were adjusted using direct standardization with the age and gender distribution of the 2000 world population and the 2001 Argentinean population [22,25–27].”
Methodde Sá, J., Alcalde-Cabero, E., Almazán‐Isla, J., Sempere, Á. P., & de Pedro‐Cuesta, J. (2012) · Neuroepidemiology · doi:10.1159/000337534 · Cited by 21
Epidemiology of systemic lupus erythematosus: Capturing the butterfly
Lim, S. S., & Drenkard, C. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0043-4 · Cited by 20
Épidémiologie de la sclérose en plaques : la particularité française
Fromont, A., Binquet, C., Clerc, L., & Moreau, T. (2009) · Revue Neurologique · doi:10.1016/j.neurol.2009.04.003 · Cited by 26
Register‐based incidence of multiple sclerosis in Brittany (north‐western France), 2000–2001
Yaouanq, J., Tron, I., Kerbrat, A., Leray, E., Hamonic, S., Mérienne, M., Hinault, P., & Edan, G. (2014) · Acta Neurologica Scandinavica · doi:10.1111/ane.12332 · Cited by 23
“While temporal fluctuations in MS incidence cannot be excluded, this support the hypothesis that latitude is not the main contributor to MS heterogeneous distribution (18, 23, 24).”
BackgroundMethodGeographical Heterogeneity of Multiple Sclerosis Prevalence in France
Pivot, D., Debouverie, M., Grzebyk, M., Brassat, D., Clanet, M., Clavelou, P., Confavreux, C., Edan, G., Leray, E., Moreau, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167556 · Cited by 22
“First, several studies have suggested that the observed heterogeneity in MS distribution could be due to an artifact in methodology [8,10,12,24].”
Bennett, D., Brayne, C., Feigin, V. L., Barker-Collo, S. L., Brainin, M., Davis, D. H. J., Gallo, V., Jetté, N., Karch, A., Kurtzke, J. F., et al. (2015) · Neuroepidemiology · doi:10.1159/000439132 · Cited by 19
Exploring the Implications of Small-Area Variation in the Incidence of Multiple Sclerosis
Green, C., Yu, B. N., & Marrie, R. A. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt092 · Cited by 15
“Although studies of other regions have reported a latitude gradient, with increasing prevalence of MS on moving away from the equator (29), we did not observe such a gradient.”
BackgroundExercise and Quality of Life in Women With Multiple Sclerosis
Giacobbi, P. R., Dietrich, F. D., Larson, R. D., & White, L. J. (2012) · Adapted Physical Activity Quarterly · doi:10.1123/apaq.29.3.224 · Cited by 16
“…for women with relapsing remitting MS. Keywords: exercise, multiple sclerosis, quality of life Multiple sclerosis (MS) is a chronic degenerative disease of the central nervous system that impacts an estimated 350,000 people in the United States and 2.5 million worldwide (Zivadinov et al., 2003).”
BackgroundInfluentialMultiple sclerosis prevalence in Salta City, Argentina
Mellinger, S., Dias, D. C. D. S., Flores, N., Palavecino, A., Vigo, G., Burgos, D., Tomas, F., Rollan, I., Herrera, G., Floridia, J., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.07.033 · Cited by 16
Prevalence of Multiple Sclerosis in the Serbian District Sumadija
Tončev, G., Drakulić, S. M., Knezevic, Z., Matić, T. B., Gavrilović, A., Tončev, S., Drulovic, J. S., & Pekmezovic, T. D. (2011) · Neuroepidemiology · doi:10.1159/000330836 · Cited by 17
Yorgun, Y. G., & Özakbaş, S. (2019) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2019.105499 · Cited by 15
Multiple Sclerosis: A Disease of Affluence?
Buchter, B., Dunkel, M., & Li, J. (2012) · Neuroepidemiology · doi:10.1159/000338676 · Cited by 19
Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998–2007
de Sá, J., Alcalde-Cabero, E., Almazán‐Isla, J., López, F. J. G., & de Pedro‐Cuesta, J. (2014) · BMC Neurology · doi:10.1186/s12883-014-0249-1 · Cited by 10
“[17] for MS incidence strata [17], and the Epidat 3.”
Isobe, N., & Oksenberg, J. R. (2014) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12078 · Cited by 14
Increasing Incidence and Prevalence of Multiple Sclerosis in Puerto Rico (2013–2016)
Chinea, A. R., Ríos‐Bedoya, C. F., Vicente, I., Rubí, C., García-García, G., Rivera, A. M., Díaz, A., Romero, E. E., Hernandez-Silvestrini, Y. G., Díaz, Y., et al. (2017) · Neuroepidemiology · doi:10.1159/000484090 · Cited by 12
Fazekas, F., Baumhackl, U., Berger, T., Deisenhammer, F., Fuchs, S., Kristoferitsch, W., Ladurner, G., Soukop, W., Wimmer, G., & Vass, K. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02943.x · Cited by 11
“Thus, the population investigated can be considered representative for CIS patients in Austria [16,17].”
BackgroundFactors associated with perceived social support of patients with multiple sclerosis
Papa, A., Koutelekos, I. G., Stefanidou, S., Chrysovitsanou, C., & Polikandrioti, M. (2021) · Current Journal of Neurology · doi:10.18502/cjn.v20i2.6741 · Cited by 17
Multiple sclerosis disease modifying medicine utilisation in Australia
Hollingworth, S., Walker, K., Page, A., & Eadie, M. J. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2014.05.034 · Cited by 6
“The DDD, as established by the World Health Organization Collaborating Centre for Drug Statistics Methodology, is the assumed average maintenance dose per day (expressed in terms of the dose contained in marketed dosage forms) for a medicine used for its main indication in adults [13].”
MethodEpidemiologic trends of multiple sclerosis in Puerto Rico (2013–2020)
Chinea, A. R., Ríos‐Bedoya, C. F., Vicente, I., Vega-Corteguera, R. J., Martínez-Maldonado, V., Carmona-Burgos, D. X., Rubí, C., Amezcua, L., Gilman, C. K., de la Matta, P. G. D., et al. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104240 · Cited by 6
Historique de la sclérose en plaques
Defer, G. L., Debouverie, M., Bardou, I., Benamar, M., Bernard‐Valnet, R., Branger, P., Brassat, D., Benallegue, N., Calocer, F., Damotte, V., et al. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-71420-7.00001-x · Cited by 7
The clinical correlates of the chair sit to stand performance in people with multiple sclerosis
Khalil, H. W., Rehan, R., Al‐Sharman, A., & El‐Salem, K. (2021) · Physiotherapy Theory and Practice · doi:10.1080/09593985.2021.1931590 · Cited by 5
“Multiple Sclerosis (MS) is one of the most common progressive neurological diseases affecting young people (Zivadinov et al., 2003).”
BackgroundIncidence and Prevalence of Multiple Sclerosis in Malmö, Southern Sweden
Alonso-Magdalena, L., Zia, E., Carmona, O., Pessah-Rasmussen, H., & Sundström, P. (2022) · Multiple Sclerosis International · doi:10.1155/2022/5464370 · Cited by 4
“This well-accepted theory of a latitudinal gradient has been challenged in the last decades with the gradient being dismissed regarding Europe and North America but still apparent for New Zealand and Australia, and with age and gender adjustments partially eliminating the latitude effect [1, 3].”
BackgroundCornea, A., Roşca, E. C., Petre, A., & Simu, M. A. (2015) · Romanian Journal of Neurology · doi:10.37897/rjn.2015.3.1 · Cited by 3
E-Muser (Enhanced Multiple Sclerosis Expected Rate): A Technical Improvement
Frumento, D. (2019) · Current Trends on Biostatistics and Biometrics · doi:10.32474/ctbb.2019.01.000115 · Cited by 2
“Some studies suggest that the above cited latitude distribution may be decreasing [6-8] and it was found that the sexual ratio (female vs male) could even be augmented over time [9-11].”
BackgroundAlelyani, M., Gameraddin, M. B., Alshahrani, R., Alaslami, W., Sarhan, R., Alghamdi, S. K., Alkhathami, A. G., Salih, S., Gareeballah, A., Hamad, Z., et al. (2024) · Medicine · doi:10.1097/md.0000000000038369 · Cited by 3
MEDICAL MANAGEMENT AND PHARMACOLOGY UPDATE
Epstein, J. B., Raber‐Durlacher, J. E., Chavarria, M.-G., & Myint, H. (2009) · Cited by 1
Utevska, S. V., & Гейко, В. В. (2018) · Faktori eksperimental noi evolucii organizmiv · doi:10.7124/feeo.v23.1021 · Cited by 1
Saini, V. A., Nadeem, M., Kolb, C., Gangloff, S., Zivadinov, R., Ramanathan, M. K., & Weinstock‐Guttman, B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800763-1.00007-5 · Cited by 1
Self-citationAbordagem fisioterapêutica da hiperatividade detrusora na Esclerose Múltipla:
Lopes, J. M., & Maciel, D. R. K. (2001) · Revista Neurociências · doi:10.34024/rnc.2012.v20.8311 · Cited by 1
Hardt, C. (2006) · Elsevier eBooks · doi:10.1016/b978-343722081-4.50007-1 · Cited by 1
Alternative data sources for estimating multiple sclerosis prevalence
Koch‐Henriksen, N. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513511879 · Cited by 1
Lee, J. D. (2014) · cIRcle (University of British Columbia) · doi:10.14288/1.0165922 · Cited by 1
“066 At last follow-up, median (IQR) 43 (34-50) 40 (34-48) 47 (38-55) 0.”
InfluentialRomano, S., Caltagirone, C., & Nocentini, U. (2011) · Springer eBooks · doi:10.1007/978-88-470-1711-5_1
Moraal, B. (2010) · Pure Amsterdam UMC
Ireland: a fine place for multiple sclerosis research
Taylor, B. V. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.234237
“For many years it has been recognised that MS prevalence varies significantly around the world, with prevalence of MS being highest in those of northwest European ancestry and increasing with latitude.(2) 3 A latitudinal gradient of MS prevalence provides the impetus for generation of a priori hypotheses regarding MS…”
BackgroundHardt, C., & Hoffmann, F. A. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22083-8.00003-1 · Cited by 1
Épidémiologie, environnement et génétique dans la sclérose en plaques
Defer, G. L., Debouverie, M., Bardou, I., Benamar, M., Bernard‐Valnet, R., Branger, P., Brassat, D., Benallegue, N., Calocer, F., Damotte, V., et al. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-71420-7.00002-1
(2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.50022-7
(2006) · Wiley eBooks · doi:10.1002/9780470041000.cedt081
Romano, S., Caltagirone, C., & Nocentini, U. (2012) · Springer eBooks · doi:10.1007/978-88-470-2676-6_2
Ruet, A. (2022) · Elsevier eBooks · doi:10.1016/b978-2-294-76331-1.00026-4
Metadata
- Authors
- Zivadinov, R., Iona, L., Monti-Bragadin, L., Bosco, A., Jurjevic, A., Taus, C., Cazzato, G., & Zorzon, M.
- Affiliations
- University of Trieste (IT)
- Azienda Sanitaria Universitaria Integrata di Trieste (IT)
- ORCID
- Zivadinov, Robert
- Venue
- Neuroepidemiology
- Publisher
- S. Karger AG
- Published
- 2003
- Volume
- 22
- Issue
- 1
- Pages
- 65-74
- ISSN
- 0251-5350 (ISSN-L)
- 1423-0208
- OpenAlex
- W2018742938
- Cited by
- 102
- References
- 80
- Citations by year
- 2024: 1 · 2022: 3 · 2021: 2 · 2019: 7 · 2018: 4 · 2017: 4 · 2016: 2 · 2015: 8 · 2014: 8 · 2013: 6 · 2012: 5
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuroepidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- multiple sclerosis, incidence, prevalence, age adjustment, sex adjustment, standardization, latitudinal gradient, regional variation, cross-study comparability
- MeSH terms
- Adolescent, Adult, Aged, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, Multiple Sclerosis, Reproducibility of Results, Incidence, Prevalence, Epidemiologic Studies, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.